Xellia Pharmaceuticals Tech Stack

Contract manufacturer of fermentation-based injectable anti-infectives and APIs

Pharmaceutical Manufacturing Copenhagen, Capital Region of Denmark 1,001–5,000 employees Founded 1903 Privately Held

Xellia manufactures active pharmaceutical ingredients and finished injectable formulations via fermentation—a process requiring regulatory precision and supply-chain durability. The tech stack is heavily weighted toward compliance infrastructure (LIMS, Active Directory, ITIL) rather than innovation tooling, and hiring is clustered in manufacturing and operations roles across a mid-seniority profile. Internal focus on pharmacovigilance, GxP audit readiness, and efficiency projects signals a company optimizing for regulatory scrutiny and cost control rather than product-line expansion.

Tech Stack 14 technologies

Core StackAutoCAD VMware Hyper-V Active Directory LIMS LC-MS/MS LC-MS Forklift IBM storage Cloudian QNAP NetApp ONTAP PowerShell ITIL

What Xellia Pharmaceuticals Is Building

◆Challenges

Compliance gaps
Gap assessments across sites
Ensuring inspection readiness
High compliance level
Internalizing qualification activities
Improving laboratory efficiency
Cost saving and efficiency projects
Spend and savings data management
Ensuring compliance with gxp regulations
Maintaining audit documentation

▲Active Projects

Annual pharmacovigilance training
Pharmacovigilance business continuity plan
Screening and selection of new pharmacovigilance vendors
Develop new sops
Conduct internal audits
Create process training materials
Ptla program
Global quality projects
Behavior-based safety programs
Local cost saving and efficiency projects

Hiring Activity

Accelerating15 roles · 10 in 30d

Department

Manufacturing

Ops

Engineering

Quality

Marketing

Procurement

Regulatory

Research

Seniority

Mid

Senior

Junior

Lead

Manager

Company intelligence

Find more companies like Xellia Pharmaceuticals by tech stack, pain points and active projects

Get started free

About Xellia Pharmaceuticals

Founded in 1903, Xellia Pharmaceuticals is a contract manufacturer specializing in fermentation-based non-beta-lactam anti-infectives and critical-care injectables. The company operates across multiple sites as a supplier to pharmaceutical firms globally, managing both active pharmaceutical ingredient production and finished dosage form manufacturing. With 1,001–5,000 employees headquartered in Copenhagen, Xellia combines long-term fermentation expertise with contract manufacturing partnerships. The operational model is built on supply continuity, regulatory compliance, and scaled production reliability rather than innovation velocity.

HeadquartersCopenhagen, Capital Region of Denmark

Company Size1,001–5,000 employees

Founded1903

Hiring MarketsHungary

Frequently Asked Questions

What technology does Xellia Pharmaceuticals use in manufacturing?

Xellia relies on LIMS (laboratory information management), LC-MS/MS and LC-MS for analytical testing, VMware and Hyper-V for infrastructure, NetApp and Cloudian for storage, and ITIL-based operational processes. Compliance and audit systems are core to the stack.

What products does Xellia Pharmaceuticals manufacture?

Xellia manufactures fermentation-based non-beta-lactam anti-infectives, active pharmaceutical ingredients, and injectable finished dosage forms for critical care. The company operates as a contract manufacturer serving other pharmaceutical firms globally.

How this profile is built

Xellia Pharmaceuticals's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.